Mountain View, CA, United States of America

Joel M Harris

This inventor holds 21 USPTO granted patents and 15 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Drug Delivery Devices. Top assignees: Incube Labs, LLC, Rani Therapeutics, LLC. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joel M Harris. Retrieved from https://idiyas.com/inventor/joel-m-harris

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 15)

% Patents Active = 71.4

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 79(Granted Patents)

Company Filing History:

Rani Therapeutics, LLC

patents

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

Clotting Factor Preparations

PCSK9 Antibody

Biodegradable Implants

Polypeptide Compositions

Transdermal Delivery

Swallowable Devices

Viable Cell Delivery

Therapeutic Agents

Solid Tissue

Pharmaceutical Compositions

Iontophoresis

Sensory Input

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12201721 - Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device (2025-01-21),

2. 12018090 - PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device (2024-06-25),

3. 11826464 - Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device (2023-11-28),

4. 11718665 - Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins (2023-08-08),

5. 11642438 - Biodegradable medical implants, polymer compositions and methods of use (2023-05-09),

6. 11464737 - Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device (2022-10-11),

7. 10869840 - Methods and articles for delivering viable cells into solid tissue (2020-12-22),

8. 10780266 - System and method for biphasic transdermal iontophoretic therapeutic agents (2020-09-22),

9. 10689460 - PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device (2020-06-23),

10. 10685577 - Systems and methods for delivering sensory input during a dream state (2020-06-16),

11. 10603275 - Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device (2020-03-31),

12. 10548851 - Methods and articles for delivering viable cells into solid tissue (2020-02-04),

13. 10242585 - Systems and methods for delivering sensory input during a dream state (2019-03-26),

14. 10227403 - Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins (2019-03-12),

15. 10220003 - Methods and articles for delivering viable cells into solid tissue (2019-03-05),

Title: Innovations of Joel M. Harris: Transforming Therapeutic Delivery Systems

Introduction: Joel M. Harris, based in Mountain View, CA, is a notable inventor with an impressive portfolio that includes 21 patents. His innovative contributions primarily focus on drug delivery systems aimed at enhancing the therapeutic efficacy of various agents within the gastrointestinal (GI) tract.

Latest Patents: Among his latest patents, Harris has developed advanced technology for the delivery of clotting factors and PCSK9 antibody preparations. The patent for clotting factor preparations introduces a swallowable drug delivery device designed to deliver therapeutic agents, such as clotting factors, directly into the intestinal wall. This system enhances absorption and allows for a more effective treatment of clotting disorders, including hemophilia. Another significant patent addresses the delivery of PCSK9 antibodies using similar swallowable devices. This innovation aims to combat cholesterol and lipid-related conditions where traditional methods face absorption challenges within the GI tract.

Career Highlights: Harris has held pivotal roles in companies such as Incube Labs, LLC and Rani Therapeutics, LLC. Throughout his career, he has focused on revolutionizing the delivery systems for therapeutic agents, leveraging his expertise to bring innovative solutions to the healthcare market. His work has significantly impacted the methodologies used to address complex medical conditions.

Collaborations: Throughout his professional journey, Harris has collaborated with notable colleagues, including Mir Imran and Mir Hashim. These partnerships exemplify the power of collective innovation in developing advanced therapeutic technologies that have the potential to change lives.

Conclusion: Joel M. Harris stands out as a prolific inventor in the field of therapeutic delivery systems. His 21 patents underscore his commitment to improving medical treatments through innovation. With ongoing projects and collaborations, Harris continues to shape the future of healthcare technology, making significant strides toward more effective therapeutic solutions.

Profile summary based on public USPTO records.